Publications

5891 Results

Recombinant human eryghropoietin (EPO) as an adjunct to radiation therapy (RT) and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study

Authors
RS Lavey;PY Liu;BE Greer;PC Cheng;WR Robinson;BJ Monk;RB Wynn;ME Conrad;D Alberts
Journal / Conference
Radiotherapy & Oncology 56(Suppl.1):S92(#330)
Year
2000
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9318

Ten-year follow-up of SWOG 8269: a phase 2 trial of concomitant cisplatin-etoposide (PE) and daily thoracic radiotherapy (TRT) in limited small cell lung cancer (L-SCLC)

Authors
CR Thomas;DJ Giroux;LM Janaki;AT Turrisi;JJ Crowley;JD McCracken;RB Livingston;DR Gandara
Journal / Conference
Radiology 217Suppl:261(#251)
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-8269

Dietary supplement use in the prostate cancer prevention trial: implications for study findings

Authors
ML Neuhouser;AR Kristal;RE Patterson;IM Thompson
Journal / Conference
American Society of Prevention Oncology :#76
Year
2000
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

High-and low-dose interferon alfa-2b in high-risk melanoma: first analysis of Intergroup trial E1690/S9111/C9190

Authors
JM Kirkwood;J Ibrahim;VK Sondak;J Richards;LE Flaherty;MS Ernstoff;TJ Smith;U Rao;M Steele;RH Blum
Journal / Conference
Journal of Clinical Oncology 18(12):2444-2458
Year
2000
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9111 (EST-1690)

Phase II evaluation of paclitaxel by 96-hour infusion in stage IIIb and IV bronchioloalveolar carcinoma (BAC)

Authors
RB Vance;JJ Crowley;D Gandara
Journal / Conference
Lung Cancer 29(Suppl.2):7(#16)
Year
2000
Research Committee(s)
Lung
Study Number(s)
S9714

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

Authors
W Sause;P Kolesar;S Taylor;D Johnson;R Livingston;R Komaki;B Emami;W Curran, Jr;R Byhardt;A Rashid Dar;A Turrisi, III
Journal / Conference
Chest 117:358-364
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Conventiional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer

Authors
EA Stadtmauer;A O'Neill;LJ Goldstein;PA Crilley;KF Mangan;JN Ingle;I Brodsky;S Martino;HM Lazarus;JK Erban;C Sickles;JH Glick
Journal / Conference
New England Journal of Medicine 342(15):1069-1076
Year
2000
Research Committee(s)
Breast
Study Number(s)
SWOG-9412

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

Authors
KR Rai;BL Peterson;FR Appelbaum;JE Kolitz;L Elias;L Shepherd;JD Hines;GA Threatte;RA Larson;BD Cheson;CA Schiffer
Journal / Conference
New England Journal of Medicine 343(24):1750-1757
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

SELECT: The selenium and vitamin E cancer prevention trial rationale and design

Authors
EA Klein;IM Thomposn;S Lippman;P Goodman;D Albanes;PR Taylor;C Coltman
Journal / Conference
Prostate Cancer and Prostatic Diseases 3:145-151
Year
2000
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Fenretinide (FEN) vs placebo in postmenopausal breast cancer patients receiving adjuvant tamoxifen (TAM), an Eastern Cooperative Oncology Group Phase III Intergroup Trial (EB193, INT-0151)

Authors
MA Cobleigh;R Gray;M Graham;L Norton;S Martino;GT Budd;JN Ingle;NE Davidson;WC Wood
Journal / Conference
Proc of the American Society of Clinical Oncology 19:86a(#328)
Year
2000
Research Committee(s)
Breast
Study Number(s)
SWOG-9514 (EB193)